Oncogeni Ltd

LONDON: Roquefort Therapeutics (LSE:ROQ), a biotech company focused on developing innovative immunology and oncology medicines, has announced a term sheet agreement for the sale of its subsidiary, Oncogeni Ltd, to The Nations Trust Holding LLC. The deal is valued at…